• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Helix BioMedix Inc

  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Programs
    • Pharma
    • Personal Care
  • News
    • Press Releases
    • Presentations
    • Scientific Publications
  • Investors
    • Stock Information
    • IR Updates
    • Proxy
    • Corporate Governance
  • Contact Page
You are here: Home / Site Map

Site Map

Pages:

  • About
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
  • Accessibility Statement for Helix BioMedix, Inc.
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Investors
    • Corporate Governance
    • IR Updates
    • Proxy
    • Stock Information
  • Licensing
  • LinkedIn
  • News
    • Presentations
    • Press Releases
    • Scientific Publications
  • Privacy Policy
  • Programs
    • Partners
    • Personal Care
    • Pharma
  • Site Map
  • Terms and Conditions
  • Contact Page

Categories:

  • Category #1

Authors:

  • K.Forsythe (3)

Monthly:

  • February 2018

Recent Posts:

  • Peptide Library
  • Our Science
  • Programs

Primary Sidebar

Footer

COMPANY PROFILE

Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum.  Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.

 

 

 

 

Terms & Conditions | Privacy Policy

Search

 

©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2025 · Executive Pro On Genesis Framework · WordPress · Log in